Tarrex Biopharma is a startup drug discovery company, located in Xiamen, a southern coastal city of China.  Tarrex is developing novel anti-cancer therapeutics through in-licensing or collaborations with universities, research institutions or other small biotech firms.  We focus on early stage programs with global intellectual property rights and develop into valuable clinical assets for out-licensing.